Psychedelics in the Treatment of Headache and Chronic Pain Disorders
- 12 May 2022
- book chapter
- Published by Springer Nature
- Vol. 56, 261-285
Abstract
The therapeutic potential of psychedelics in headache and chronic pain disorders is documented over decades of anecdotal and early investigational reports, which have paved the way for the first controlled studies of psilocybin and lysergic acid diethylamide (LSD) in these disorders. The reported lasting clinical effects after limited dosing with psychedelics present a novel means for disease management, but considerable further study will be required to address disease-specific treatments, uncover mechanism(s) of action, and verify safety. In this chapter, these topics are reviewed with particular attention to the neurobiological systems that offer potential sources of psychedelics’ unique clinical effects in headache and pain. Keywords Chronic Pain Cluster Headache Headache LSD Migraine Psilocybin PsychedelicsKeywords
This publication has 102 references indexed in Scilit:
- What Happens to the Old Headache Medicines?Headache: The Journal of Head and Face Pain, 2012
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinProceedings of the National Academy of Sciences, 2012
- Intravenous dihydroergotamine for inpatient management of refractory primary headachesNeurology, 2011
- Diencephalic and brainstem mechanisms in migraineNature Reviews Neuroscience, 2011
- Origin of pain in migraine: evidence for peripheral sensitisationThe Lancet Neurology, 2009
- History of Methysergide in MigraineCephalalgia, 2008
- Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology, 2008
- Studying sex and gender differences in pain and analgesia: A consensus reportPain, 2007
- Typical Cluster Headache Caused by Granulomatous Pituitary InvolvementCephalalgia, 2007
- Phantom Limb Pain: Sub‐Hallucinogenic Treatment With Lysergic Acid Diethylamide (LSD‐25)Headache: The Journal of Head and Face Pain, 1977